Literature DB >> 33634374

TUFT1 Facilitates Metastasis, Stemness, and Vincristine Resistance in Colorectal Cancer via Activation of PI3K/AKT Pathway.

Yang Yang1, Tao Zhang2, Lixiang Wu1.   

Abstract

Since the incidence and mortality of colorectal cancer (CRC) are increasing in recent years, the research on the pathogenesis of colorectal cancer has attracted more and more attention. Here, our results confirmed that the mRNA expression level and proteins accumulation of TUFT1 were significantly increased in CRC tissues from late-stage CRC patients (III + IV) (p < 0.001), indicated by qPCR and IHC assay. The TUFT1 expression was positively correlated with tumor stage by analyzing 126 specimens from CRC patients. Next, we found that up-regulation of TUFT1 enhanced the migration and invasion of LoVo cells, whereas the down-regulation of TUFT1 observably weakened the migration and invasion of SW837 cells, indicating that TUFT1 promotes the metastasis of CRC cells. In addition, TUFT1 overexpression increased the number of mammary spheres and vincristine resistance of LoVo cells by sphere formation assay and measuring the IC50 value, suggesting the TUFT1 promotes stemness and the vincristine resistance of CRC cells. Finally, we found that TUFT1 overexpression increased p-AKT in LoVo cells, while down-regulation of TUFT1 decreased the p-AKT levels in SW837 cells. Therefore, we determined that the function of TUFT1 in CRC depends on PI3K/AKT pathway. Taken together, these data demonstrated that TUFI1 facilitates metastasis, stemness, and vincristine resistance of colorectal cancer cells via activation of PI3K/AKT pathway, which might act as a promising therapeutic target for CRC.

Entities:  

Keywords:  Colorectal cancer (CRC); PI3K/AKT; Stemness; TUFI1; Vincristine

Year:  2021        PMID: 33634374     DOI: 10.1007/s10528-021-10051-0

Source DB:  PubMed          Journal:  Biochem Genet        ISSN: 0006-2928            Impact factor:   1.890


  44 in total

1.  Molecular cloning and characterization of the bovine and human tuftelin genes.

Authors:  M M Bashir; W R Abrams; T Tucker; B Sellinger; M Budarf; B Emanuel; J Rosenbloom
Journal:  Connect Tissue Res       Date:  1998       Impact factor: 3.417

2.  PTBP1 knockdown overcomes the resistance to vincristine and oxaliplatin in drug-resistant colon cancer cells through regulation of glycolysis.

Authors:  Chuanyao Cheng; Zhihui Xie; Yanhua Li; Jianjun Wang; Changjiang Qin; Yanru Zhang
Journal:  Biomed Pharmacother       Date:  2018-09-13       Impact factor: 6.529

Review 3.  The human tuftelin gene and the expression of tuftelin in mineralizing and nonmineralizing tissues.

Authors:  D Deutsch; Y Leiser; B Shay; E Fermon; A Taylor; E Rosenfeld; L Dafni; K Charuvi; Y Cohen; A Haze; A Fuks; Z Mao
Journal:  Connect Tissue Res       Date:  2002       Impact factor: 3.417

4.  Colorectal cancer.

Authors:  Herb Brody
Journal:  Nature       Date:  2015-05-14       Impact factor: 49.962

Review 5.  Colorectal cancer.

Authors:  Evelien Dekker; Pieter J Tanis; Jasper L A Vleugels; Pashtoon M Kasi; Michael B Wallace
Journal:  Lancet       Date:  2019-10-19       Impact factor: 79.321

Review 6.  Therapeutic Potential of Targeting PI3K/AKT Pathway in Treatment of Colorectal Cancer: Rational and Progress.

Authors:  Afsane Bahrami; Majid Khazaei; Malihe Hasanzadeh; Soodabeh ShahidSales; Mona Joudi Mashhad; Marjaneh Farazestanian; Hamid Reza Sadeghnia; Majid Rezayi; Mina Maftouh; Seyed Mahdi Hassanian; Amir Avan
Journal:  J Cell Biochem       Date:  2017-05-15       Impact factor: 4.429

7.  Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence?

Authors:  Tamer Colakoglu; Sedat Yildirim; Fazilet Kayaselcuk; Tarik Zafer Nursal; Ali Ezer; Turgut Noyan; Hamdi Karakayali; Mehmet Haberal
Journal:  Am J Surg       Date:  2008-04-28       Impact factor: 2.565

8.  Regulation of drug resistance and metastasis of gastric cancer cells via the microRNA647-ANK2 axis.

Authors:  Wenlong Cao; Weiyuan Wei; Zexu Zhan; Dongyi Xie; Yubo Xie; Qiang Xiao
Journal:  Int J Mol Med       Date:  2018-01-11       Impact factor: 4.101

9.  Hypoxia-induced TUFT1 promotes the growth and metastasis of hepatocellular carcinoma by activating the Ca2+/PI3K/AKT pathway.

Authors:  Changwei Dou; Zhenyu Zhou; Qiuran Xu; Zhikui Liu; Yuqun Zeng; Yufeng Wang; Qing Li; Liang Wang; Wei Yang; Qingguang Liu; Kangsheng Tu
Journal:  Oncogene       Date:  2018-09-24       Impact factor: 8.756

10.  The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo.

Authors:  Min-Wu Chao; Mei-Jung Lai; Jing-Ping Liou; Ya-Ling Chang; Jing-Chi Wang; Shiow-Lin Pan; Che-Ming Teng
Journal:  J Hematol Oncol       Date:  2015-07-10       Impact factor: 17.388

View more
  1 in total

1.  Clinical and molecular evaluation of patients with ovarian cancer in the context of drug resistance to chemotherapy.

Authors:  Marcin Opławski; Agata Średnicka; Ewa Niewiadomska; Dariusz Boroń; Piotr Januszyk; Beniamin Oskar Grabarek
Journal:  Front Oncol       Date:  2022-08-05       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.